# Efficacy of Topical Tapinarof Versus Betamethasone in the Treatment of Plaque Psoriasis

> **NCT07635043** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Pakistan Institute of Medical Sciences** · enrollment: 120 (estimated)

## Conditions studied

- Psoriasis (PsO)

## Interventions

- **DRUG:** Betamethasone Dipropionate 0.05% Cream
- **DRUG:** Tapinarof Cream 1%

## Key facts

- **NCT ID:** NCT07635043
- **Lead sponsor:** Pakistan Institute of Medical Sciences
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2026-10-31
- **Final completion:** 2026-11-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07635043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07635043, "Efficacy of Topical Tapinarof Versus Betamethasone in the Treatment of Plaque Psoriasis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07635043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*